Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
526
NCT00044226
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2002
Completion: Oct 31, 2002
NCT04788355
Prevention of Complications (SARS-CoV-2): Clinical Study
Phase: Phase 3
Role: Collaborator
Start: Jul 1, 2020
Completion: Dec 23, 2020